NEULASTA pegfilgrastim rbe 6mg/0.6mL injection syringe with stelmi needle shield

Země: Austrálie

Jazyk: angličtina

Zdroj: Department of Health (Therapeutic Goods Administration)

Aktivní složka:

Pegfilgrastim, Quantity: 6 mg

Dostupné s:

Amgen Australia Pty Ltd

Léková forma:

Injection, solution

Složení:

Excipient Ingredients: sodium; water for injections; sorbitol; polysorbate 20; acetate

Podání:

Subcutaneous

Jednotky v balení:

1 x 1 prefilled syringe

Druh předpisu:

(S4) Prescription Only Medicine

Terapeutické indikace:

For the treatment of cancer patients following chemotherapy to decrease the duration of severe neutropenia, and so reduce the incidence of infection, as manifested by febrile neutropenia.

Přehled produktů:

Visual Identification: clear, colourless liquid; Container Type: Syringe; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Stav Autorizace:

Licence status A

Datum autorizace:

2002-09-26